Largest Indian pharma M&A in final lap; PE firm GTCR only other contender. A portfolio company of Advent International, Zentiva will significantly boost Aurobindo’s European footprint.
from Healthcare/Biotech-Industry-Economic Times https://ift.tt/Sa0FGJC
via IFTTT
-
Acquista ********, Ossicodone, Ketamina, Ozempic (WhatsApp: +31616337954) I nostri prodotti hanno una purezza del 98-99%. E-mail di cont...
-
So I’m currently on a lean bulk on 2900 a day. And I wake up 6 am I have oats and protein powder or fruit then go gym around 9 am Then at ...
-
Kotak Alternate Asset Managers has announced a Rs 1,445 crore investment in the acquisition of Viatris' active pharmaceutical ingredient...
Search This Blog
Powered by Blogger.
Blog Archive
-
▼
2025
(521)
-
▼
August
(33)
- Aurobindo Pharma closing in on $5.5b Zentiva buyout
- Indian drugmakers seek exemption for generics from...
- Glenmark, Alembic Pharma, Sun Pharma recall produc...
- Alembic gets USFDA nod for generic drug for skin c...
- Aurobindo Pharma expects China plant to break even...
- Food Chained: How weight-loss drugs are changing I...
- Max Healthcare to nearly double capacity to 9,500 ...
- Cohance Lifesciences announces $10 million investm...
- From burden to breakthrough: Reimagining the #Weig...
- Intas Pharma completes acquisition of UDENYCA bios...
- Lupin ties up with Sandoz to commercialise biosimi...
- Chemists seek ban on quick commerce sale of prescr...
- Asia Healthcare Holdings to invest Rs 400 crore in...
- Pfizer launches next-gen vaccine for pneumococcal ...
- Welcure Drugs & Pharma board to consider share spl...
- Zydus Lifesciences gets USFDA approval for angina,...
- Retinal disorders a public health crisis, need imm...
- Managing diabetes in a country obsessed with quick...
- Govt gives BIS exemption to parts used in medical ...
- Biocon sees GLP-1 weight-loss therapy as a future ...
- Medical device firms sound the alarm over new stee...
- Weight-loss drug Mounjaro crosses Rs 100 crore sal...
- Novo Nordisk's Wegovy, Mounjaro sales in India dou...
- Executive order by US administration excludes Phar...
- Indian pharma on alert as US mulls higher drug tar...
- More heart attacks in diabetes? Here’s what you sh...
- Indian generics wave next year set to sink obesity...
- Eris Lifesciences eyes ‘good’ share in semaglutide...
- Pharma tariffs may go as high as 250%, says Trump
- Mind, muscle, and metabolism: The power of holisti...
- Corner Office Conversation with The New Leaders of...
- Manipal Hospitals seeks CCI nod to acquire Sahyadr...
- 70% enrolment of participants for Phase III clinic...
-
▼
August
(33)
Recent Posts
Unordered List
Theme Support
-
Text Widget
Design by FlexiThemes | Blogger Theme by Lasantha - PremiumBloggerTemplates.com | Best Gadgets | Distributed By Gooyaabi Templates
0 comments:
Post a Comment